Skip to main navigation

Home
Overview
News & Events
- Press Releases
- Events and Presentations
Stock Information
- Stock Quote & Chart
- Analyst Coverage
Financials
Governance
IR Resources
- Email Alerts
- Contact IR

Events and Presentations

Events and Presentations

Corporate Presentation

Corporate Presentation May 2023

May 22, 2023

Latest Presentations

More information is coming soon.

Investor
Scientific

Upcoming Events

More events are coming soon.

Past Events

December 7, 2022 at 2:00 PM EST

Virtual R&D Event: Enhancing the HGF/MET System to Fight Neurodegenerative Diseases

August 4, 2022

Phase II Drug Development for Alzheimer’s Disease: Athira Pharma

August 3, 2022

ACT-AD: Fosgonimeton in Mild-to-Moderate Alzheimer’s Disease – First Results of a Randomized, Placebo-Controlled, 26-Week, Phase 2 Proof-of-Concept Trial

August 2, 2022

Fosgonimeton, a Novel, Small-Molecule Positive Modulator of the HGF/MET System, is Neuroprotective in Primary Neuron Culture

July 31, 2022

Development of Stable, Orally Bioavailable, Small-Molecule Positive Modulators of HGF/MET Signaling for the Treatment of Cognitive Impairment

March 20, 2022

Study Design and Participant Characteristics of a Phase 2 Trial of Fosgonimeton, a Novel Treatment for Mild to Moderate Alzheimer’s Disease

March 2, 2022

Positive Modulation of Hepatocyte Growth Factor/MET by a Novel Small Molecule Induces Neurotrophic and Procognitive Effects

March 2, 2022

Oral Small Molecule Hepatocyte Growth Factor/MET Positive Modulator ATH-1020 Reduces Depression-like Behaviors and Normalizes Pathological EEG Mismatch Negativity in Preclinical Models

November 10, 2021 at 11:50 AM EST

Athira Pharma to Present Updates from Phase 2/3 Trials of ATH-1017 at the 2021 Clinical Trials on Alzheimer’s Disease (CTAD) Conference

November 5, 2021 at 12:00 PM EDT

Educational Webinar on the Clinical Applications of ERP P300

SIGN UP FOR EMAIL ALERTS

CONTACT IR

Athira Pharma, Inc.
18706 North Creek Parkway
Suite 104
Bothell, WA 98011

Main line: (866) 725-0930
Local number: (425) 620-8501
info@athira.com

© Athira Pharma, Inc. All rights reserved.